New User? Sign Up | Sign In

Insider Trading - Countouriotis Athena

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

Insider Trading Transactions for Countouriotis Athena

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-04-22
Purchase
2019-04-24
5:55 pm
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
12,000 $18 $216,000 12,000
(Direct)
View
2019-09-10
Purchase
2019-09-11
4:15 pm
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
10,000 $45 $450,000 22,000
(Direct)
View
2020-03-03
Purchase
2020-03-03
6:37 pm
Passage BIO Inc. PASG Countouriotis Athena
Director
8,900 $18 $160,200 8,900
(Direct)
View
2020-03-24
Purchase
2020-03-25
8:26 pm
Passage BIO Inc. PASG Countouriotis Athena
Director
10,000 $14.98 $149,750 18,900
(Direct)
View
2020-05-21
Purchase
2020-05-26
5:55 pm
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
4,166 $60 $249,960 26,872
(Direct)
View
2021-02-09
Sale
2021-02-11
8:28 pm
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
60,000 $137.48 $8,249,038 50,195
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-06-30
Exercise
2016-07-05
4:55 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
6,450 $0 20,088
(Direct)
View
2016-06-30
Tax Withholding
2016-07-05
4:55 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
107 $8.63 19,981
(Direct)
View
2016-06-30
Option Award
2016-07-05
4:55 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
6,450 $0 6,450
(Direct)
View
2016-06-30
Exercise
2016-07-05
4:55 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
6,450 $0 0
(Direct)
View
2017-01-05
Exercise
2017-01-09
4:03 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
7,500 $0 27,481
(Direct)
View
2017-01-05
Exercise
2017-01-09
4:03 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
7,500 $0 15,000
(Direct)
View
2017-02-03
Exercise
2017-02-06
7:01 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
18,496 $0 45,977
(Direct)
View
2017-02-03
Tax Withholding
2017-02-06
7:01 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
6,900 $12.26 39,077
(Direct)
View
2017-02-03
Exercise
2017-02-06
7:01 pm
N/A
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
18,496 $0 55,487
(Direct)
View
2017-02-22
Option Award
2017-02-24
4:06 pm
2018-02-22
2027-02-22
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
72,925 $0 72,925
(Direct)
View
2017-02-22
Option Award
2017-02-24
4:06 pm
2018-02-22
N/A
HALOZYME THERAPEUTICS INC HALO Countouriotis Athena
SVP and Chief Medical Officer
45,568 $0 45,568
(Direct)
View
2017-06-19
Option Award
2017-06-21
6:11 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Countouriotis Athena
SVP Chief Medical Officer
150,000 $0 150,000
(Direct)
View
2017-06-19
Option Award
2017-06-21
6:11 pm
N/A
2027-06-18
Adverum Biotechnologies Inc. ADVM Countouriotis Athena
SVP Chief Medical Officer
213,000 $0 213,000
(Direct)
View
2018-01-23
Option Award
2018-01-25
5:00 pm
2019-01-23
2028-01-23
Trovagene Inc. TROV Countouriotis Athena
Director
54,322 $0 92,428
(Direct)
View
2018-02-15
Option Award
2018-02-20
7:16 pm
N/A
2028-02-14
Adverum Biotechnologies Inc. ADVM Countouriotis Athena
SVP Chief Medical Officer
160,000 $0 160,000
(Direct)
View
2019-06-10
Option Award
2019-06-11
5:16 pm
N/A
2029-06-09
IOVANCE BIOTHERAPEUTICS Inc IOVA Countouriotis Athena
Director
35,000 $0 35,000
(Direct)
View
2019-06-20
Option Award
2019-06-24
4:05 pm
2020-06-20
2029-06-20
Trovagene Inc. TROV Countouriotis Athena
Director
44,734 $0 46,019
(Direct)
View
2020-01-06
Option Award
2020-01-08
4:24 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
706 $31.13 22,706
(Direct)
View
2020-01-06
Option Award
2020-01-08
4:24 pm
N/A
2030-01-05
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
325,000 $0 325,000
(Direct)
View
2020-02-27
Option Award
2020-03-02
6:05 pm
N/A
2030-02-27
Passage BIO Inc. PASG Countouriotis Athena
Director
33,836 $0 33,836
(Direct)
View
2020-06-08
Option Award
2020-06-10
8:00 pm
N/A
2030-06-07
IOVANCE BIOTHERAPEUTICS Inc IOVA Countouriotis Athena
Director
35,000 $0 35,000
(Direct)
View
2021-02-08
Option Award
2021-02-10
5:52 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
22,617 $0 50,195
(Direct)
View
2021-02-08
Option Award
2021-02-10
5:52 pm
N/A
2031-02-07
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
101,775 $0 101,775
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
18,000 $3.2 68,195
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
7,666 $3.2 75,861
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
25,392 $3.2 75,587
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
8,942 $3.2 59,137
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
2028-06-05
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
18,000 $0 207,723
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
2028-06-05
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
7,666 $0 67,575
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
2028-06-05
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
25,392 $0 182,331
(Direct)
View
2021-02-09
Exercise
2021-02-11
8:28 pm
N/A
2028-06-05
Turning Point Therapeutics Inc. TPTX Countouriotis Athena
CEO
8,942 $0 173,389
(Direct)
View
2021-05-27
Option Award
2021-05-28
5:50 pm
N/A
2031-05-26
Passage BIO Inc. PASG Countouriotis Athena
Director
16,918 $0 16,918
(Direct)
View